Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Spero Therapeutics Inc (NQ: SPRO)
8.570 USD  +0.120 (+1.42%)
Streaming Delayed Price  /  Updated: 11:06 AM EST, Nov 13, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 6,672
Open 8.610
Bid (Size) 8.550 (7)
Ask (Size) 8.740 (1)
Prev. Close 8.450
Today's Range 8.440 - 8.957
52wk Range 7.800 - 19.00
Shares Outstanding 14,377,753
Dividend Yield N/A
Performance
YTD
-29.41%
-29.41%
1 Month
-12.19%
-12.19%
3 Month
-22.79%
-22.79%
6 Month
-24.89%
-24.89%
1 Year
-41.90%
-41.90%
Top News
More News
Spero Therapeutics Announces Third Quarter 2018 Financial Results and Pipeline Overview
Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant (MDR)... Read More
from GlobeNewswire News Releases
Spero Therapeutics Announces Positive Results from SPR720 IND-Enabling Studies and Plans to Initiate a Phase 1 Trial
Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant (MDR)... Read More
from GlobeNewswire News Releases
More News
Read More
New Research: Key Drivers of Growth for IDT, Live Nation Entertainment, BioDelivery Sciences International, Spero Therapeutics, Aimmune Therapeutics, and Cars — Factors of Influence, Major Initiatives
from GlobeNewswire News Releases
Spero Therapeutics Receives QIDP Designation from the U.S. FDA for the Development of SPR206
from GlobeNewswire News Releases
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2018
from PR Newswire
Spero Announces Positive SPR994 Phase 1 SAD/MAD Final Results
from GlobeNewswire News Releases
Spero Therapeutics Announces Presentations at IDWeek 2018
from GlobeNewswire News Releases
Spero Therapeutics to Present at the Cantor Global Healthcare Conference in October
from GlobeNewswire News Releases
Short Interest In Spero Therapeutics Plummets 56.6%
category Stocks
from Market News Video
Component Price Targets Imply 22% Gains Ahead For Russell 2000
category ETFs
from ETF Channel
Mid-Day Market Update: Dow Rises Over 350 Points; Hanwha Q CELLS Shares Spike Higher
category FFHL , NDLS , Benzinga , and 15 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.